Roche and Genentech warn of counterfeit Avastin

02/14/2012 | Reuters · Wall Street Journal, The

Roche Holding and its unit Genentech reported that a fake version of their injectable cancer drug Avastin was found in the U.S. The FDA is investigating and has alerted medical practices about the counterfeit product.

View Full Article in:

Reuters · Wall Street Journal, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ